(Q61921370)
Statements
A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Ozarelix, in Patients With Lower Urinary Tract Symptoms(LUTS)Due to Benign Prostatic Hypertrophy (BPH) (English)
0 references
January 2007
0 references
April 2008
0 references
76
0 references
50 year
0 references